Cytokine-dependent activation of small hepatocyte-like progenitor cells in retrorsine-induced rat liver injury

被引:8
作者
Best, D. Hunter [1 ]
Butz, Genelle M. [1 ]
Coleman, William B. [1 ,2 ,3 ,4 ]
机构
[1] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Sch Med, Curniculum Toxicol, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Sch Med, Program Translat Med, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
关键词
Liver regeneration; Small hepatocyte-like progenitor cells; Glucocorticoid; Pyrrolizidine alkaloid; Cytokine; IL6; NECROSIS-FACTOR RECEPTOR; MICE LACKING TYPE-1; PARTIAL-HEPATECTOMY; EXPOSED RATS; OVAL CELLS; INTERLEUKIN-6-DEFICIENT MICE; DEOXYRIBONUCLEIC ACID; GROWTH-FACTORS; LEAD NITRATE; REGENERATION;
D O I
10.1016/j.yexmp.2009.10.009
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Complete liver regeneration after partial hepatectomy (PH) in rats exposed to the pyrrolizidine alkaloid retrorsine is accomplished through the activation, expansion, and differentiation of a population of small hepatocyte-like progenitor cells (SHPCs). The mechanism(s) governing activation of SHPCs after PH in retrorsine-injured rats has not been investigated. We examined the possibility that SHPCs require cytokine priming prior to becoming growth factor responsive in this model of liver injury and regeneration. Male Fischer 344 rats were treated with retrorsine (30 mg/kg ip) at 6 and 8 weeks of age. Retrorsine-exposed and age-matched control rats were randomized into dexamethasone-treated and no DEX groups. DEX-treated animals were either given a single dose of DEX (2 mg/kg ip) at the time of PH or multiple DEX treatments (2 mg/kg ip each) at 24 and 1 h before PH and 1, 2, and 3 days post-PH. A subset of rats received 10 mu g of recombinant IL6 protein, administered intravenously 30 min after PH. Liver tissues were harvested at 7, 14, 21, and 30 days post-PH. Treatment of retrorsine-exposed rats with the cytokine inhibitor dexamethasone (DEX) effectively blocked the emergence of SHPCs resulting in an inhibition of liver regeneration and producing significant short-term mortality. The livers of DEX-treated retrorsine-exposed rats displayed decreased numbers and smaller SHPC clusters compared to retrorsine-exposed rats in the absence of DEX treatment. Administration of recombinant IL6 to DEX-treated retrorsine-exposed rats restored the emergence of SHPCs and SHPC-mediated regenerative response. The livers of DEX-treated retrorsine-exposed rats that received IL6 displayed numbers of expanding SHPC clusters comparable to that of retrorsine-exposed rats in the absence of DEX treatment. These results combine to suggest that SHPC activation after PH in retrorsine-exposed rats is cytokine dependent and may specifically require IL6. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:7 / 14
页数:8
相关论文
共 36 条
[1]   ANTIBODIES TO TUMOR-NECROSIS-FACTOR-ALPHA INHIBIT LIVER-REGENERATION AFTER PARTIAL-HEPATECTOMY [J].
AKERMAN, P ;
COTE, P ;
YANG, SQ ;
MCCLAIN, C ;
NELSON, S ;
BAGBY, GJ ;
DIEHL, AM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (04) :G579-G585
[2]   Bile duct destruction by 4,4-diaminodiphenylmethane does not block the small hepatocyte-like progenitor cell response in retrorsine-exposed rats [J].
Best, D. Hunter ;
Coleman, William B. .
HEPATOLOGY, 2007, 46 (05) :1611-1619
[3]   Treatment with 2-AAF blocks the small hepatocyte-like progenitor cell response in retrorsine-exposed rats [J].
Best, D. Hunter ;
Coleman, William B. .
JOURNAL OF HEPATOLOGY, 2007, 46 (06) :1055-1063
[4]   Interleukin 6 is important for survival after partial hepatectomy in mice [J].
Blindenbacher, A ;
Wang, XY ;
Langer, I ;
Savino, R ;
Terracciano, L ;
Heim, MH .
HEPATOLOGY, 2003, 38 (03) :674-682
[5]  
BUCHER NLR, 1964, CANCER RES, V24, P1611
[6]  
Coleman W. B., 1998, LIVER GROWTH REPAIR, P50
[7]  
Coleman WB, 2004, ADULT STEM CELLS, P101
[8]   Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice [J].
Cressman, DE ;
Greenbaum, LE ;
DeAngelis, RA ;
Ciliberto, G ;
Furth, EE ;
Poli, V ;
Taub, R .
SCIENCE, 1996, 274 (5291) :1379-1383
[9]  
DABEVA MD, 1993, P SOC EXP BIOL MED, V204, P242
[10]  
EVARTS RP, 1989, CANCER RES, V49, P1541